Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1141169

Cover Image

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1141169

Cell & Gene Therapy Clinical Trials Market Research Report by Phase, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

PUBLISHED:
PAGES: 225 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Online Access - 1 Year (Single User License)
USD 3949
PDF, Excel & Online Access - 1 Year (Single User License)
USD 4949
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 5949
PDF, Excel & Online Access - 1 Year (Site License)
USD 7949
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 9949

Add to Cart

The Global Cell & Gene Therapy Clinical Trials Market size was estimated at USD 5,248.64 million in 2021 and expected to reach USD 5,914.70 million in 2022, and is projected to grow at a CAGR 12.94% to reach USD 10,895.54 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Cell & Gene Therapy Clinical Trials to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Phase, the market was studied across Phase I, Phase II, Phase III, and Phase IV.

Based on Application, the market was studied across Cardiology, CNS, Dermatology, Endocrine, Metabolic, Genetic, Gastroenterology, Hematology, Immunology & Inflammation, Infectious Diseases, Musculoskeletal, Oncology, and Ophthalmology.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell & Gene Therapy Clinical Trials market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell & Gene Therapy Clinical Trials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell & Gene Therapy Clinical Trials Market, including Accell Clinical Research, LLC, Atlant Clinical Ltd., Charles River Laboratories International, Inc., Eli Lilly and Company, ICON Plc, IQVIA Inc., Laboratory Corporation Of America Holdings, Medpace Holdings, Inc., Novartis AG, Novo Nordisk A/S, Novotech Pty Limited, Parexel International Corporation, Pfizer Inc., Ppd, Inc., ProPharma Group Holdings, LLC, SGS S.A., Syneos Health, Inc., Thermo Fisher Scientific Inc., Veristat, Llc, and Wuxi AppTec Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Cell & Gene Therapy Clinical Trials Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell & Gene Therapy Clinical Trials Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell & Gene Therapy Clinical Trials Market?
  • 4. What is the competitive strategic window for opportunities in the Global Cell & Gene Therapy Clinical Trials Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Cell & Gene Therapy Clinical Trials Market?
  • 6. What is the market share of the leading vendors in the Global Cell & Gene Therapy Clinical Trials Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Cell & Gene Therapy Clinical Trials Market?
Product Code: MRR-0D217D5AEB7B

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing application of cell & gene therapy in cancer research
      • 5.1.1.2. Rising number of chronic diseases worldwide
      • 5.1.1.3. Increasing investment and funding from government and biotechnology and biopharmaceutical companies for cell-based research
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cell & gene therapy clinical trials
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing regulatory approvals for cell & gene therapies
      • 5.1.3.2. Increasing adoption of advanced technologies for cell & gene therapy clinical trials
    • 5.1.4. Challenges
      • 5.1.4.1. Challenge in effective data analysis
  • 5.2. Cumulative Impact of COVID-19

6. Cell & Gene Therapy Clinical Trials Market, by Phase

  • 6.1. Introduction
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. Cell & Gene Therapy Clinical Trials Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiology
  • 7.3. CNS
  • 7.4. Dermatology
  • 7.5. Endocrine, Metabolic, Genetic
  • 7.6. Gastroenterology
  • 7.7. Hematology
  • 7.8. Immunology & Inflammation
  • 7.9. Infectious Diseases
  • 7.10. Musculoskeletal
  • 7.11. Oncology
  • 7.12. Ophthalmology

8. Americas Cell & Gene Therapy Clinical Trials Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cell & Gene Therapy Clinical Trials Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cell & Gene Therapy Clinical Trials Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis, By Key Player
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Accell Clinical Research, LLC
    • 12.1.1. Business Overview
    • 12.1.2. Key Executives
    • 12.1.3. Product & Services
  • 12.2. Atlant Clinical Ltd.
    • 12.2.1. Business Overview
    • 12.2.2. Key Executives
    • 12.2.3. Product & Services
  • 12.3. Charles River Laboratories International, Inc.
    • 12.3.1. Business Overview
    • 12.3.2. Key Executives
    • 12.3.3. Product & Services
  • 12.4. Eli Lilly and Company
    • 12.4.1. Business Overview
    • 12.4.2. Key Executives
    • 12.4.3. Product & Services
  • 12.5. ICON Plc
    • 12.5.1. Business Overview
    • 12.5.2. Key Executives
    • 12.5.3. Product & Services
  • 12.6. IQVIA Inc.
    • 12.6.1. Business Overview
    • 12.6.2. Key Executives
    • 12.6.3. Product & Services
  • 12.7. Laboratory Corporation Of America Holdings
    • 12.7.1. Business Overview
    • 12.7.2. Key Executives
    • 12.7.3. Product & Services
  • 12.8. Medpace Holdings, Inc.
    • 12.8.1. Business Overview
    • 12.8.2. Key Executives
    • 12.8.3. Product & Services
  • 12.9. Novartis AG
    • 12.9.1. Business Overview
    • 12.9.2. Key Executives
    • 12.9.3. Product & Services
  • 12.10. Novo Nordisk A/S
    • 12.10.1. Business Overview
    • 12.10.2. Key Executives
    • 12.10.3. Product & Services
  • 12.11. Novotech Pty Limited
    • 12.11.1. Business Overview
    • 12.11.2. Key Executives
    • 12.11.3. Product & Services
  • 12.12. Parexel International Corporation
    • 12.12.1. Business Overview
    • 12.12.2. Key Executives
    • 12.12.3. Product & Services
  • 12.13. Pfizer Inc.
    • 12.13.1. Business Overview
    • 12.13.2. Key Executives
    • 12.13.3. Product & Services
  • 12.14. Ppd, Inc.
    • 12.14.1. Business Overview
    • 12.14.2. Key Executives
    • 12.14.3. Product & Services
  • 12.15. ProPharma Group Holdings, LLC
    • 12.15.1. Business Overview
    • 12.15.2. Key Executives
    • 12.15.3. Product & Services
  • 12.16. SGS S.A.
    • 12.16.1. Business Overview
    • 12.16.2. Key Executives
    • 12.16.3. Product & Services
  • 12.17. Syneos Health, Inc.
    • 12.17.1. Business Overview
    • 12.17.2. Key Executives
    • 12.17.3. Product & Services
  • 12.18. Thermo Fisher Scientific Inc.
    • 12.18.1. Business Overview
    • 12.18.2. Key Executives
    • 12.18.3. Product & Services
  • 12.19. Veristat, Llc
    • 12.19.1. Business Overview
    • 12.19.2. Key Executives
    • 12.19.3. Product & Services
  • 12.20. Wuxi AppTec Inc.
    • 12.20.1. Business Overview
    • 12.20.2. Key Executives
    • 12.20.3. Product & Services

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
Product Code: MRR-0D217D5AEB7B

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2021 VS 2027
  • FIGURE 3. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 4. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
  • FIGURE 5. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 6. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
  • FIGURE 7. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 8. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 9. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
  • FIGURE 10. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET DYNAMICS
  • FIGURE 11. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2021 VS 2027 (%)
  • FIGURE 12. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2021 VS 2027 (USD MILLION)
  • FIGURE 13. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY PHASE, 2027
  • FIGURE 14. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2018-2027 (USD MILLION)
  • FIGURE 15. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2018-2027 (USD MILLION)
  • FIGURE 16. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2018-2027 (USD MILLION)
  • FIGURE 17. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE IV, 2018-2027 (USD MILLION)
  • FIGURE 18. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
  • FIGURE 19. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
  • FIGURE 20. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
  • FIGURE 21. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CARDIOLOGY, 2018-2027 (USD MILLION)
  • FIGURE 22. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CNS, 2018-2027 (USD MILLION)
  • FIGURE 23. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY DERMATOLOGY, 2018-2027 (USD MILLION)
  • FIGURE 24. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ENDOCRINE, METABOLIC, GENETIC, 2018-2027 (USD MILLION)
  • FIGURE 25. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GASTROENTEROLOGY, 2018-2027 (USD MILLION)
  • FIGURE 26. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGY, 2018-2027 (USD MILLION)
  • FIGURE 27. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, 2018-2027 (USD MILLION)
  • FIGURE 28. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2027 (USD MILLION)
  • FIGURE 29. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY MUSCULOSKELETAL, 2018-2027 (USD MILLION)
  • FIGURE 30. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
  • FIGURE 31. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY OPHTHALMOLOGY, 2018-2027 (USD MILLION)
  • FIGURE 32. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 33. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 34. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 35. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
  • FIGURE 36. ARGENTINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 37. BRAZIL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 38. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 39. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 40. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 41. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
  • FIGURE 42. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
  • FIGURE 43. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
  • FIGURE 44. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 45. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 46. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 47. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
  • FIGURE 48. AUSTRALIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 49. CHINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 50. INDIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 51. INDONESIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 52. JAPAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 53. MALAYSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 54. PHILIPPINES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 55. SINGAPORE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 56. SOUTH KOREA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 57. TAIWAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 58. THAILAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 59. VIETNAM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 60. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 61. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 62. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 63. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
  • FIGURE 64. DENMARK CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 65. EGYPT CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 66. FINLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 67. FRANCE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 68. GERMANY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 69. ISRAEL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 70. ITALY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 71. NETHERLANDS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 72. NIGERIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 73. NORWAY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 74. POLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 75. QATAR CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 76. RUSSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 77. SAUDI ARABIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 78. SOUTH AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 79. SPAIN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 80. SWEDEN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 81. SWITZERLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 82. TURKEY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 83. UNITED ARAB EMIRATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 84. UNITED KINGDOM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 85. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET: FPNV POSITIONING MATRIX, 2021
  • FIGURE 86. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2021
  • FIGURE 87. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021

LIST OF TABLES

  • TABLE 1. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
  • TABLE 3. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 4. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 6. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 7. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2018-2027 (USD MILLION)
  • TABLE 8. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 9. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2018-2027 (USD MILLION)
  • TABLE 11. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 12. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2018-2027 (USD MILLION)
  • TABLE 14. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 15. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE IV, 2018-2027 (USD MILLION)
  • TABLE 17. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 20. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CARDIOLOGY, 2018-2027 (USD MILLION)
  • TABLE 21. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 22. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 23. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CNS, 2018-2027 (USD MILLION)
  • TABLE 24. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CNS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CNS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 26. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY DERMATOLOGY, 2018-2027 (USD MILLION)
  • TABLE 27. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 28. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 29. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ENDOCRINE, METABOLIC, GENETIC, 2018-2027 (USD MILLION)
  • TABLE 30. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ENDOCRINE, METABOLIC, GENETIC, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 31. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ENDOCRINE, METABOLIC, GENETIC, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 32. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GASTROENTEROLOGY, 2018-2027 (USD MILLION)
  • TABLE 33. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 34. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 35. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGY, 2018-2027 (USD MILLION)
  • TABLE 36. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 37. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 38. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, 2018-2027 (USD MILLION)
  • TABLE 39. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 40. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 41. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2027 (USD MILLION)
  • TABLE 42. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 43. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 44. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY MUSCULOSKELETAL, 2018-2027 (USD MILLION)
  • TABLE 45. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 46. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 47. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
  • TABLE 48. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 49. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 50. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY OPHTHALMOLOGY, 2018-2027 (USD MILLION)
  • TABLE 51. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 52. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 53. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 54. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 55. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 56. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 57. ARGENTINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 58. ARGENTINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 59. ARGENTINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 60. BRAZIL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 61. BRAZIL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 62. BRAZIL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 63. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 64. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 65. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 66. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 67. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 68. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 69. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 70. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
  • TABLE 71. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 72. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 77. AUSTRALIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 78. AUSTRALIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 79. AUSTRALIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 80. CHINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 81. CHINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 82. CHINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 83. INDIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 84. INDIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 85. INDIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 86. INDONESIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 87. INDONESIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 88. INDONESIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 89. JAPAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 90. JAPAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 91. JAPAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 92. MALAYSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 93. MALAYSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 94. MALAYSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 95. PHILIPPINES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 96. PHILIPPINES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 97. PHILIPPINES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 98. SINGAPORE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 99. SINGAPORE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 100. SINGAPORE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 101. SOUTH KOREA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 102. SOUTH KOREA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 103. SOUTH KOREA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 104. TAIWAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 105. TAIWAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 106. TAIWAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 107. THAILAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 108. THAILAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 109. THAILAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 110. VIETNAM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 111. VIETNAM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 112. VIETNAM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 117. DENMARK CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 118. DENMARK CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 119. DENMARK CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 120. EGYPT CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 121. EGYPT CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 122. EGYPT CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 123. FINLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 124. FINLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 125. FINLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 126. FRANCE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 127. FRANCE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 128. FRANCE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 129. GERMANY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 130. GERMANY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 131. GERMANY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 132. ISRAEL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 133. ISRAEL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 134. ISRAEL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 135. ITALY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 136. ITALY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 137. ITALY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 138. NETHERLANDS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 139. NETHERLANDS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 140. NETHERLANDS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 141. NIGERIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 142. NIGERIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 143. NIGERIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 144. NORWAY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 145. NORWAY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 146. NORWAY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 147. POLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 148. POLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 149. POLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 150. QATAR CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 151. QATAR CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 152. QATAR CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 153. RUSSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 154. RUSSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 155. RUSSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 159. SOUTH AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 162. SPAIN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 163. SPAIN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 164. SPAIN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 165. SWEDEN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 166. SWEDEN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 167. SWEDEN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 168. SWITZERLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 169. SWITZERLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 170. SWITZERLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 171. TURKEY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 172. TURKEY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 173. TURKEY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 174. UNITED ARAB EMIRATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 175. UNITED ARAB EMIRATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 176. UNITED ARAB EMIRATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 177. UNITED KINGDOM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 178. UNITED KINGDOM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
  • TABLE 179. UNITED KINGDOM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 180. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
  • TABLE 181. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
  • TABLE 182. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
  • TABLE 183. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET RANKING, BY KEY PLAYER, 2021
  • TABLE 184. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2021
  • TABLE 185. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET MERGER & ACQUISITION
  • TABLE 186. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 187. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 188. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET INVESTMENT & FUNDING
  • TABLE 189. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 190. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET: LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!